Clinical Cases Podcast Series-FREE NO CME-IR Opioid Cross Taper to Buprenorphine Example

IR Opioid Cross Taper to Buprenorphine Example

Pdf Summary

This document is a patient guidance tool for transitioning from short-acting (immediate-release) opioid pain medications to buprenorphine/naloxone (Suboxone) using a gradual “cross-taper” (microinduction) over about two weeks. It is intended for patients taking typical IR opioid regimens such as hydrocodone/acetaminophen (Norco) 10/325 mg, oxycodone/acetaminophen (Percocet) 10/325 mg, oxycodone IR 10 mg, or morphine sulfate IR (MSIR) 15–30 mg, generally 3–4 times daily. The goal is to move to a safer, potentially more effective pain-management option while maintaining pain control and minimizing withdrawal.<br /><br />Key safety steps include prescribing naloxone and providing education for the patient and support persons on how to use it to reduce overdose death risk.<br /><br />The toolkit explains how to use Suboxone 2 mg/0.5 mg sublingual films, including cutting films to create small starting doses. It provides a day-by-day schedule: starting at 1/4 film daily (Day 1), increasing to twice daily dosing, then gradually increasing to 1–2 films twice daily by Days 4–6. During this period, the patient continues their full opioid dose initially, then reduces to 75% around Day 4 and to 50% by Day 7. In the second week, Suboxone dosing becomes more individualized (potentially split 2–4 mg doses multiple times per day for better pain relief), while the opioid is reduced further to 25% and then stopped by Day 14 (or used only as-needed briefly).<br /><br />The document adds dosing-conversion help for achieving 75%, 50%, and 25% reductions for common hydrocodone/oxycodone and morphine IR regimens. It emphasizes close follow-up with the prescribing provider and notes that high Suboxone doses per administration are rarely necessary for patients starting from these opioid dose ranges.

Keywords

buprenorphine

naloxone

Suboxone

microinduction

cross-taper

opioid transition

immediate-release opioids

withdrawal management

pain control

naloxone education